FindTrial
Sign In

Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).

Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030740
Enrollment
Unknown
Registered
2020-03-13
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

case series:no

Sponsors

Shandong Provincial Chest hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who were diagnosed as COVID-19 by nucleic acid test; 2. ARDS patients are defined According to the Berlin definition.

Exclusion criteria

Exclusion criteria: 1. Aged<14 years; 2. Pneumothorax; 3. Severe asthma or COPD.

Design outcomes

Primary

MeasureTime frame
mortality;ICU hospital stay;mechanical ventilation time;mortality of 28 days;—

Secondary

MeasureTime frame
total hospital stay;—

Countries

China

Contacts

Public ContactFenglin Liu

Shandong Provincial Chest Hospital

xkyylfl@163.com+86 13953116564

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026